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Medication storage temperatures in primary response 
vehicles
Christopher Stein
To the Editor: Paramedics practising pre-hospital emergency 
advanced life support care carry a range of parenteral 
medications including antiarrhythmics, analgesics, hypnotics 
and anticonvulsants.1 Unless otherwise indicated, medications 
should be stored at controlled room temperature (CRT) to limit 
accelerated thermal degradation caused by temperatures above 
CRT.2
Compliance of storage temperatures with CRT can be 
determined by measuring the mean kinetic temperature used 
in place of the arithmetical mean of a set of temperature 
measurements because the former takes into account the 
greater contribution of higher temperatures to thermal 
degradation of medications.3 CRT storage conditions are 
exceeded if the mean kinetic temperature over a period of 
time exceeds 25°C, if any temperature over that period of time 
exceeds 40°C, or if temperature spikes between 30°C and 40°C 
occur that exceed 24 hours during that period.2
In South Africa, medications are typically kept permanently 
in a primary response vehicle until used for patient care or 
are discarded. Currently there is no recommendation, nor is 
it standard practice, to take any special precautions to keep 
medication storage temperatures within CRT in these vehicles. 
Therefore, medications are exposed to storage temperatures 
which may be above CRT, possibly for long periods.
The aim of this study was to document medication storage 
temperatures over a continuous 12-month period in the drug 
storage compartment of a typical primary response vehicle 
under operational conditions in Johannesburg.
Methods
Two electronic temperature data loggers (Model 42270 
temperature/humidity data logger, Extech Instruments, 
Mass., USA) were placed in the drug storage compartment 
of a primary response vehicle (2003 Toyota Corolla RSI). 
Temperatures were recorded at 30-minute intervals between 
1 August 2004 and 31 July 2005, and stored in an electronic 
spreadsheet application. Mean kinetic temperatures were 
calculated using a validated software application (Stability 
System II [MKT] version 1.6, ScienTek Software Inc., Calif., 
USA).
Results
Over the study period, 17 449 temperature measurements 
were recorded and downloaded.The highest single maximum 
temperature recorded was 40.5°C in December 2004. Monthly 
mean kinetic temperatures were above the threshold 
recommended for compliance with CRT (25°C) for a period of 
6 consecutive months (Fig. 1). The mean kinetic temperature 
for the period October 2004 - March 2005 (26.9°) was also above 
CRT, while the overall mean kinetic temperature over the entire 
12-month period was 24.7°C.
Discussion
The effects of deviations from CRT on the chemical stability 
of any medications were not examined. Concerns may be 
justified regarding the accelerated degradative effects of high 
medication storage temperatures, considering that the mean 
kinetic temperature was above the recommended threshold 
over the 6 hottest months of the year.
Duration of exposure to higher temperatures must also 
be an important factor in determining degradative effects 
on medications stored in primary response vehicles. This 
knowledge can enable medications with a high turnover to be 
protected from the damaging effects of prolonged exposure 
to higher temperatures. The vehicle design can also influence 
drug storage temperatures; for example, a hatchback allows the 
vehicle’s air conditioning system to reduce temperatures in the 
drug storage area while driving. The study vehicle was not a 
hatchback.
A study is under way to quantify chemical degradation 
occurring in selected medications (adrenaline, atropine, 
midazolam, diazepam and morphine) after storage in a primary 
response vehicle.
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Fig. 1. Medication storage temperature in a primary response vehicle.
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Bipolar diathermy for the outpatient control of posterior 
epistaxis
B J McKenzie, J W Loock
To the Editor: Epistaxis remains a major cause of emergency 
otolaryngology admissions.
Epistaxis is classified as anterior or posterior. Anterior 
bleeding sites are bleeders anterior to the bony nasal aperture, 
and are relatively easy to manage because the vessel may 
be visualised and controlled with basic equipment such as a 
headlight, nasal suction device and nasal speculum and simple 
cautery techniques. 
Posterior epistaxis, which originates posterior to the bony 
nasal aperture, poses a more difficult problem. Generally these 
bleeders are not visible without the use of nasal endoscopy, 
especially if they occur on the lateral wall of the nasal cavity, a 
complex anatomical area characterised by the turbinate bones 
and meati, which have recesses between them.  
As a result of these factors the traditional treatment of 
posterior bleeds has been the use of ‘blind’ techniques of nasal 
packing with ribbon gauze soaked in BIPP (bisthmus iodine 
and phosphate paste) and inflating the balloon of a Foley`s 
catheter in the patient's nasopharynx (this allows for control of 
the epistaxis where the actual bleeding site is not specifically 
identified). 
However, newer technology in the form of nasal endoscopes 
and bipolar nasal cautery probes potentially permits the 
localisation and cauterisation of the bleeding site in an awake 
patient in an outpatient setting. Nasal endoscopy and a bipolar 
diathermy probe have been found effective in localising the 
source of bleeding in the outpatient clinic, in the hands of an 
expert and dedicated nasal endoscopist.1,2
Blind nasal packing is the management protocol for patients 
presenting with posterior epistaxis in tertiary academic 
hospitals in South Africa, as was our department’s policy 
before this study. These patients all had their noses packed, 
were observed as inpatients and had the packs removed 48 
hours later. When the pack failed to control the epistaxis the 
patient would be taken to theatre for localisation of the bleeder 
and diathermy, or endoscopic sphenopalatine artery ligation. 
If this failed, embolisation of the internal maxillary artery was 
performed. 
We conducted an audit looking at the management of 100 
successive patients with epistaxis admitted to our institution 
during 2004. The protocol described above resulted in 
prolonged hospital stays (average for posterior epistaxis 82 
hours) and a low incidence of direct localisation of the bleeding 
site (only 7.7% of posterior sites, 1/13, were localised). By 
comparison a national survey in the UK revealed that the mean 
duration of stay in hospital was 70 hours for epistaxis patients, 
and that 20% of patients admitted to otolaryngology units were 
managed by direct control of the bleeding point.3 
We therefore decided to investigate the viability of 
localisation and cautery as a primary intervention for posterior 
epistaxis in the context of a South African training hospital. 
Methods
A prospective study was undertaken on patients presenting to 
the Tygerberg Hospital ENT department with active posterior 
epistaxis between 1 June 2006 and 1 October 2007. All patients 
with traumatic epistaxis, any coagulopathy or Osler-Weber-
Rendu syndrome, and those younger than 18 years of age, were 
excluded from the study.
The sample consisted of both patients who presented to 
our department directly and those referred to us. Any packs 
inserted before presentation at Tygerberg Hospital were 
removed. Any anterior bleeding source was cauterised and 
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the patient discharged. Only patients with active posterior 
bleeding sources were included in the study.
The nose was initially cleared of any blood or clots by 
suction and blowing the nose. Before endoscopy the rate of 
bleeding was reduced using pledgelets soaked in 2 ml of 10% 
cocaine. The nose was inspected with a 2.7 mm, 25o rigid 
nasal endoscope and repeated suctioning. Once the source 
of the bleeding was located, the cocaine pledgelets were re-
introduced over that specific site to achieve haemostasis.
The bleeding source was then cauterised using a guarded 
bipolar diathermy probe. Patients in whom the bleeding was 
controlled were admitted for overnight observation, without 
any nasal packing. Patients in whom primary control of the 
bleeding failed were packed with an anterior and, if necessary, 
a posterior pack and then taken to the operating theatre for 
definitive management. 
Results
Fourteen patients fulfilled the inclusion criteria. Their ages 
ranged from 28 to 73 years, with a mean age of 58 years. There 
were 9 men and 5 women.  The site of bleeding was localised 
to the nasal septum in 10 patients (71%) and to the lateral nasal 
wall in 3 (21%), while 1 patient (7%) had a combination of 
bleeding sites.
Eleven (79%) of the 14 patients had successful localisation 
and cautery of the bleeding site, with no subsequent bleeding 
during the 24-hour observation period. We were unable to 
control the bleeding in the outpatient department in 3 patients 
(21%), who were packed and taken to theatre for further 
management.
Of the 14 patients in the study, 1 returned with epistaxis. 
He was the first of those needing definitive control in theatre, 
synechiae having obstructed the initial endoscopic view. He 
presented the second time 4 months after the sphenopalatine 
artery ligation, and on this occasion the source was successfully 
visualised and controlled in the outpatient department using 
the endoscopic protocol.    
Discussion
Our study confirmed that most posterior bleeding sites 
can be successfully localised using nasal endoscopy and a 
systematic examination of the nasal cavity. In 10 (71%) of our 
14 patients the site of bleeding was the nasal septum, which 
is in keeping with other authors’ findings.4 The fact that most 
bleeding sites are not located in the more complex lateral nasal 
wall, a significant factor in permitting accurate localisation 
of the bleeder, contributed to the high success rates in this 
management protocol.
Correct technique is important, and while active bleeding 
is necessary for localisation of the bleeder, excessive bleeding 
makes visualisation of the specific vessel difficult and prevents 
effective cautery. Attention to haemorrhage control before 
endoscopy is a key element in successful localisation. Others 
have used a combination of cocaine and local infiltration 
of adrenaline through a spinal needle to reduce persistent 
bleeding.3 We found topical cocaine effective. As the bleeding 
subsides the endoscopy more easily reveals the site of bleeding, 
and the cocaine pack can be placed more accurately over the 
bleeding vessel. We found that the vessel is usually fairly 
prominent, often protruding from the septum at 90o. Initial 
attempts at cautery often resulted in the recurrence of bleeding. 
The cocaine pledgelet was then repositioned over the bleeder, 
and cautery repeated once bleeding had stopped.    
We admitted our patients for observation overnight because 
of socio-economic issues limiting access to transport, should 
the patients rebleed, and because this was a new protocol for 
our department. Patients in whom a single, prominent bleeding 
site was localised and cauterised did not rebleed and were 
discharged the following morning. Their hospital stay was 
significantly shortened to 20 hours from a previous mean of 82 
hours.
Our results indicate that direct localisation of the posterior 
bleed should become the routine, first-line management in 
the treatment of posterior epistaxis. However, our numbers 
are small and the study is limited as there was only one 
investigator. We are now investigating the applicability of this 
technique to all registrar trainees in our department.   
Conclusion
Endoscopic examination in cases of posterior epistaxis enables 
the source of bleeding to be localised and controlled in a high 
proportion of cases. The benefits to the patient, hospital, doctor 
and health care system are significant. This should become the 
routine management of posterior epistaxis in ENT departments 
in South Africa that have the facility of nasal endoscopy, and in 
private ENT practice. 
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